Gault Cheryl sold RAPP
March 5, 2026 · Form 4 insider transaction
Gault Cheryl sold 2,014 shares of Rapport Therapeutics, Inc. at $28.93 per share, a transaction worth $58.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.34 to $28.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.